Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 79.30
-2.00 (-2.46%)
Oct 12, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 13.28 billion as of October 9, 2026. It is the 15,984th most valuable company in the world and the 593rd biggest in Taiwan. Its market cap has decreased by 70.91% in one year.
Market Cap
13.28B
Enterprise Value
12.66B
Revenue
34.37M
Global Rank
Country Rank
#593 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 13.28B, an increase of 209.24%. That is a compound annual growth rate of 10.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 13.28B | -59.47% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 20.38B |
| TaiMed Biologics | 16.72B |
| Ever Supreme Bio Technology | 16.27B |
| Steminent Biotherapeutics | 15.43B |
| EirGenix | 15.32B |
| ACRO Biomedical | 15.27B |
| Gongwin Biopharm Holdings | 14.41B |
| AP Biosciences | 12.97B |